KNAW

Back to search results
Dr. E. Vreugdenhil Person

Dr. E. Vreugdenhil

Pagina-navigatie:


Update Persondata


Export page
Expertise RNA-interference in vivo; si-RNA molecules as novel drugs
Expertise (NL) RNA-interference in vivo; si-RNA molecules als nieuw geneesmiddel

Active as

Researcher
Organisation Leiden Academic Centre for Drug Research (LACDR) (UL)
Email vreugden -at- lacdr. leidenuniv. nl
URL http://medpharm.lacdr.gorlaeus.net/people/vreugdenhil
Associate professor
Organisation Department of Neuropharmacology (UL)
Chair (EN) Medical Pharmacology, Molecular Neurobiology
Chair (NL) Medische Farmacologie, Moleculaire Neurobiologie
Phone +31-71-5276230
Email vreugden -at- lacdr. leidenuniv. nl
URL http://medpharm.lacdr.gorlaeus.net/people/vreugdenhil

Current research

(the most recent research is at the top)
Co-supervisor Functional Consequences of overexpression of Doublecortin Like Kinase gene products in the mouse hippocampus: Implications for development of epilepsy
Co-supervisor In vivo application of RNA-interference: Targeting doublecortin-like (DCL) in the mouse hippocampus

Completed research projects

(the most recent research is at the top)
Project leader How does the stress system influence pharmaco-resistance mechanism in epileptic mice
Project leader Target validation: Behavioral consequences for cognition of gene knockdown using RNA-interference technology
Co-supervisor Doublecortin-like kinase: a potential therapeutic target for neuroblastoma
Co-supervisor Glucocorticoid receptor knockdown and adult hippocampal neurogenesis
Co-supervisor Doublecortin-like kinase and neuronal differentiation
All completed research..

Classification

D23340 Biopharmacology, toxicology

Go to page top
Go back to contents
Go back to site navigation